Evaluation of the Efficacy of OMK2 in Recovering Corneal Neural Damage in Patients With Diabetes
NCT03906513
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Cornea
Interventions
DEVICE:
OMK2
Sponsor
University of Milan